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Abstract
Noninvasive cardiac imaging is a cornerstone of the diagnostic work-up in patients
with suspected coronary artery disease (CAD), cardiomyopathy, heart failure, and
congenital heart disease. It is essential for the assessment of CAD from functional
and anatomical perspectives, and is considered the gate-keeper to invasive coronary
angiography. Cardiac tests include exercise electrocardiography, single photon
emission computed tomography myocardial perfusion imaging, positron emission
tomography myocardial perfusion imaging, stress echocardiography, coronary
computed tomography angiography, and stress cardiac magnetic resonance. The
wide range of imaging techniques is advantageous for the detection and manage‐
ment of cardiac diseases, and the implementation of preventive measures that can
affect the long-term prognosis of these diseases. However, clinicians face a chal‐
lenge when deciding which test is most appropriate for a given patient. Basic
knowledge of each modality will facilitate the decision-making process in CAD as‐
sessment.
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1. Introduction
Noninvasive cardiac imaging is crucial for coronary artery disease (CAD) assessment. The
increasing global burden of CAD is a major contributor to the marked growth in the use of
noninvasive imaging [1]. In recent years, the development of state-of-the-art hardware and
software technologies has broadened the perspective and dimension of noninvasive imaging.
This is advantageous to hybrid imaging in CAD assessment, with the introduction of anatom‐
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
ical, physiological, or combined approaches. These techniques allow clinicians to move beyond
the dichotomous concept of the presence or absence of CAD by increasing their understanding
of the unique pathophysiologic processes in CAD, including subclinical atherosclerosis,
plaque vulnerability, myocardial blood flow (MBF), and scar detection.
Invasive coronary angiography (ICA), an anatomical test, is considered the gold standard
method for the diagnosis of CAD. Nevertheless, the risk of complications precludes the routine
use of ICA and it is only indicated in patients with a high pre-test probability of the disease [2].
Because most patients have low or intermediate pre-test probabilities of disease, noninvasive
testing should be considered first, serving as a selection process for ICA. Clinicians can choose
from a wide range of noninvasive tests, including exercise electrocardiography (ECG), single
photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI),
positron emission tomography (PET) MPI, stress echocardiography (SE), coronary computed
tomography angiography (CCTA), and stress cardiac magnetic resonance (CMR). Therefore,
clinicians are frequently faced with the apparently difficult clinical question: “What is the right
test?” However, there are no right tests! The test to be used should be selected for each patient
after considering the patient’s characteristics, genetic and environmental factors, predisposi‐
tion, risk factors, and comorbidities. Cardiac testing is generally unnecessary in asymptomatic
patients except in high-risk occupations or before starting antiarrhythmic drugs.
A basic understanding of the principles, diagnostic, and prognostic accuracy, and the strengths
and limitations of each imaging technique is essential. The clinician must then adopt a
structured approach, which will help choose the appropriate test to use after considering the
risk and benefit profile of each test. The establishment of a diagnosis of CAD will influence the
perceived likelihood of a future cardiac event and warrant secondary prevention to slow or
prevent disease progression. The absence of CAD on imaging will reassure the patient, and
encourage the clinician to adopt a primary prevention strategy. Hence the ultimate goal is for
the chosen test to address the clinical question with a high level of certainty. The theme of this
chapter is to provide a comprehensive guide to selecting the appropriate imaging test in
patients with suspected CAD.
2. Basic concepts for choosing cardiac imaging tests
2.1. Classification of chest pain
There can be varied presentation of chest pain, including jaw pain, epigastric pain, indigestion,
shortness of breath, or reduced effort tolerance. Atypical presentations are commonly seen
among diabetics, female, and the elderly. Chest pain can be classified using the criteria below
[3]:
Criteria:
1. Substernal chest pain or discomfort
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2. Provoked by exertion or emotional stress
3. Relieved by rest ± nitroglycerin
Typical angina: (1) + (2) + (3)
Atypical angina: (1) + (2) or (1) + (3)
Nonanginal chest pain: (1) or none.
2.2. Pre-test and post-test probabilities
Bayes’ theorem proposes the use of a combined pre-test probability and test result to determine
the post-test probability of disease [4]. This will help the clinician to determine whether a
positive test result is a “true positive” or a “false positive” and whether a negative test result
is a “true negative” or a “false negative”. For example, a positive test result is likely to be a
“true positive” result in a 70-year-old patient with typical angina or a “false positive” result
in a 40-year-old female with nonanginal chest pain. Meanwhile, a negative test result is likely
to be a “true negative” result in a 35-year-old man with atypical chest pain or a “false negative”
result in a 60-year-old man with prior myocardial infarction (MI) and typical angina. Pretest
probability can be estimated using the Diamond and Forrester classification [5] (Table 1).
Age Gender Typical Atypical Nonanginal
(years) Angina Angina chest pain
≤ 39 Men Intermediate Intermediate Low
Women Intermediate Very low Very low
40-49 Men High Intermediate Intermediate
Women Intermediate Low Very low
50-59 Men High Intermediate Intermediate
Women Intermediate Intermediate Low
≥ 60 Men High Intermediate Intermediate
Women High Intermediate Intermediate
Table 1. Diamond and Forrester Pre-Test Probability of Coronary Artery Disease by Age, Sex, and Symptoms. High:
>90% pre-test probability. Intermediate: between 10% and 90% pre-test probability. Low: between 5 and 10% pre-test
probability. Very low: <5% pre-test probability [5].
2.3. Appropriate use criteria
The appropriate use criteria (AUC) defines appropriate imaging for the different clinical
indications. The AUC for test selection among symptomatic patients with suspected CAD [2]
(Table 2).
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Indication for noninvasive testing in Exercise Stress Stress Stress CCTA
symptomatic patients ECG MPI Echo CMR
Low pretest probability of CAD
ECG interpretable AND able to exercise A R M R R
Low pretest probability of CAD
ECG uninterpretable OR unable to exercise A A M M
Intermediate pretest probability of CAD
ECG interpretable AND able to exercise A A A M M
Intermediate pretest probability of CAD
ECG uninterpretable OR unable to exercise A A A A
High pretest probability of CAD
ECG interpretable AND able to exercise M A A A M
High pretest probability of CAD
ECG uninterpretable OR unable to exercise A A A M
Table 2. Appropriate Use Criteria for noninvasive testing in symptomatic patients for CAD assessment. A=
appropriate, M= maybe appropriate, R= rarely appropriate. Uninterpretable ECG refers to resting abnormalities such
as ST-segment depression (≥ 0.10 mV), complete left bundle branch block (LBBB), pre-excitation, digoxin use, or
ventricular paced rhythm [2].
3. Non-invasive imaging tests
This section will focus on the unique principles, diagnostic and prognostic accuracy, strengths,
limitations, representative cases and clinical pearls for each imaging modality.
3.1. Exercise electrocardiography
3.1.1. Background
Exercise ECG is a well-established and validated functional test used for CAD assessment. It
has been used for more than 50 years, despite the increasing use of other imaging modalities.
It is the first-line test in patients with suspected CAD who are able to exercise and who have
an interpretable resting ECG [2]. Studies have demonstrated a lower diagnostic accuracy of
exercise ECG in women because of their lower prevalence of CAD. However the risk of major
adverse cardiac events (MACE) in women with good functional capacity and a normal resting
ECG was not different between those who underwent exercise ECG compared with exercise
SPECT MPI, and exercise ECG was considered a cost-effective strategy [6].
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3.1.2. Principles
Exercise ECG evaluates the physiological response of the heart to a controlled level of exercise.
The latter can be prescribed using specific exercise protocols such as Bruce and Naughton.
Exercise ECG and hemodynamic-specific variables are shown to have diagnostic and prog‐
nostic value in the assessment of CAD. These variables include ST deviation, exercise capacity,
percentage of the maximum age-predicted target heart rate (HR), heart rate recovery (HRR),
blood pressure (BP) response, and the Duke Treadmill Score (DTS) [7].
Abnormal ST deviation is defined as ≥1 mm (0.1 mV) of downsloping or horizontal ST-segment
depression (J point + 80 ms); or ≥1 mm of ST segment elevation in leads without pathological
Q waves (except aVR). The J-point is defined as the junction of the QRS complex and the ST-
segment. The ST deviation should be seen in three or more consecutive beats in the same lead
to be considered significant [8, 9]. An upsloping ST-segment depression is considered an
“equivocal” response and is not suggestive of myocardial ischemia [10]. High risk features
include ST-segment depression ≥ 2mm at < 5 metabolic equivalents (METs) in ≥5 leads and ≥5
minutes into recovery [11]. ST-segment elevation in two or more contiguous leads can help
localize the site of significant ischemia, unlike ST-segment depression [12]. In the presence of
prior Q waves, ST-segment elevation of > 1.0 mm (J point +60 ms) is considered abnormal. This
could represent reversible ischemia in the peri-infarct zone or ventricular dyskinesis or
akinesis of a segment of the left ventricle. This finding has been demonstrated among patients
with anterior (~30%) and inferior (~15%) infarctions [13, 14].
Exercise capacity (a marker of cardiorespiratory fitness) is an estimate of the maximal oxygen
uptake for a given workload, and is measured in METs [15]. The prevalence of significant
ischemia was 0.4% and 7.1%, based on the workload achieved (≥10 METs and < 7 METs),
respectively, on exercise SPECT MPI [16]. Hence, patients who are able to achieve a high
workload (≥10 METs) on exercise ECG, may not require additional functional imaging.
The maximum age-predicted HR is usually described as “220-age”. The inability to achieve
85% of the maximum age-predicted HR was associated with decreased survival [17].
HRR is calculated as the peak HR achieved (HR at 1 min) [18]. An abnormal HRR is defined
as a decrease in the HR of < 12 bpm in the first minute of recovery, and is predictive of mortality.
A normal blood pressure (BP) response is defined as an increase in systolic BP and an increase
or decrease in diastolic BP during exercise. A decrease in systolic BP of >10 mmHg may suggest
the presence of acute left ventricular dysfunction owing to ischemia [7]. An abnormal BP
response may be a specific marker for left main (LM) or triple vessel disease (TVD) [19].
The DTS is calculated as exercise time (minutes) – (5 x ST depression in mm) – (4 x angina
index) (0= no angina; 1= nonlimiting angina; 2= limiting angina) [20]. DTS can be categorized
into low risk (≥ +5), intermediate risk (-10 to +4) and high risk (≤ -11).
The absolute and relative contraindications for undergoing and termination of an exercise
ECG, respectively, is illustrated in Table 3 and Table 4 [9].
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
39
Absolute Relative
Acute myocardial infarction (<48 hours) Obstructive left main stenosis
Unstable angina Moderate aortic stenosis
Decompensated heart failure Hypertrophic obstructive cardiomyopathy with severe
resting gradient
Active endocarditis
Significant tachyarrhythmias or bradyarrhythmias
Uncontrolled cardiac arrhythmias High degree atrioventricular (AV) block
Severe symptomatic aortic stenosis Recent stroke or transient ischemic attack
Acute pulmonary embolism Mental impairment with limited ability to cooperate
Acute myocarditis or pericarditis Uncontrolled BP >200/100 mmHg
Acute aortic dissection Uncorrected medical conditions, e.g. significant anemia,
important electrolyte imbalance, and hyperthyroidism
Physical disability that precludes safe and adequate testing
Table 3. Absolute and relative contraindications for undergoing exercise ECG [9]
Absolute Relative
ST segment elevation (> 1.0 mm) in leads without
preexisting Q waves (other than aVR, aVL and V1)
Marked ST displacement (horizontal or downsloping of >2
mm measured 60 to 80 ms after the J point
Drop in systolic BP >10 mmHg, despite an increase in
workload, in the presence of ischemia
Drop in systolic BP >10 mmHg, despite an increase in
workload, in the absence of ischemia
Moderate to severe angina Worsening chest pain
Central nervous system symptoms (e.g. ataxia, dizziness) Fatigue, shortness of breath, wheezing, leg cramps or
claudication
Signs of poor perfusion Tachyarrhythmias, including multifocal ectopy, ventricular
triplets, supraventricular tachycardia
Sustained ventricular tachycardia (VT), 2nd or 3rd degree
AV block
Bradyarrhythmias that potentially become more complex
or result in hemodyamic instability
Technical difficulties in monitoring the ECG or BP BP >250/115 mmHg
Patient's request to stop Development of bundle branch block which is
indistinguishable from VT
Table 4. Absolute and relative indications for termination of exercise ECG [9]
3.1.3. Diagnostic and prognostic accuracy
A meta-analysis evaluating the accuracy of exercise ECG reported a sensitivity of 68% and
specificity of 77% for the detection of CAD [21]. The discriminatory cut-off point of 1 mm (0.1
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mV) of horizontal or downsloping ST-segment depression had a sensitivity of 68% and
specificity of 77% [22]. The frequency of significant CAD in patients with low, intermediate,
and high DTS was 19.1%, 34.9%, and 89.2%, respectively. In patients with LM or TVD, the
frequency of significant CAD was 3.5%, 12.4%, and 46% in patients with low, intermediate,
and high DTS, respectively [23]. The 5-year survival rates in patients with a DTS of ≤ -11 and
≥ +7, were 67% and 93%, respectively[24]. In a recent study of 58,020 adults without CAD, the
peak METs and the percentage of the maximum predicted HR were highly predictive of
survival [25].
In relation to other imaging modalities, significant risk predictors for hard cardiac events in
asymptomatic or symptomatic low-risk patients without CAD included abnormal SPECT
findings (hazard ratio [HR] = 1.83), ischemia detected by exercise ECG (HR = 1.70), decreasing
exercise capacity (HR = 1.11), decreasing DTS (HR = 1.07), and increasing severity of the
coronary calcium score (CS) (HR = 1.29). The CS improved the long-term risk prediction for
CAD when stratified according to the Framingham Risk Score [26].
3.1.4. Strengths and limitations
The strengths and limitations of an exercise ECG are shown in Table 5.
Strengths Limitations
Cheap Low sensitivity
Widely available Low specificity
No radiation exposure Unable to localise
ischemic territory
No injection
Short procedural time
Assess exercise capacity
Table 5. Strengths and limitations of exercise ECG
3.1.5. Case example 1
A 71-year-old man presents with atypical chest pain, able to exercise, and a normal resting
ECG. Risk factors include ex-smoker and hypertension. Pretest probability of CAD is inter‐
mediate. Based on the AUC, exercise ECG is considered an appropriate test. Resting ECG
revealed sinus rhythm at a HR of 61 bpm (Figure 1A). He underwent exercise ECG using Bruce
protocol. He exercised for 7 minutes 31 seconds and achieved 10.1 METS. At 6 minutes into
the exercise and at a HR of 121 bpm, ECG demonstrated 1 mm horizontal ST-segment
depression in leads II, III, aVF, V3 to V6 and reached a maximum of 3 mm at peak stress at HR
of 151 bpm in leads II, III, and aVF (Figure 1B). The changes resolved at 1 minutes 50 seconds
during recovery. Test was terminated due to fatigue. He developed chest pain at recovery. The
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calculated DTS = -11.5. Conclusion: Abnormal exercise ECG with a high DTS. He was referred
for ICA.
ȱ
(a)ȱ
ȱ
(b)ȱ
FIGUREȱ1A:ȱNormalȱrestingȱECG.ȱFigureȱ1B:ȱMaximumȱofȱ3ȱmmȱhorizontalȱSTȱsegmentȱdepressionȱseenȱ
ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ ȱ
Figure 1. (a) Normal resting ECG. (b) Maximum of 3 mm horizontal ST segment depression seen in leads II, III and
aVF, 2 mm ST segment depression in leads V3 to V6, at peak stress.
3.1.6. Clinical pearls
1. The J-point is defined as the junction of the QRS complex and the ST segment.
2. Achieving 85% of age predicted HR should not be an indication for test termination.
3. Exercise ECG with a high DTS may warrant ICA.
4. Exercise duration and METs achieved are strong predictors of prognosis.
5. The modification in ECG lead placement during exercise ECG compared to standard ECG
may result in shift of the frontal axis to the right, increasing the voltage in the inferior
leads, disappearance of Q waves in a patient with prior inferior infarct, or produce
artifactual Q waves in normal subjects.
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3.2. Single photon emission computed tomography
3.2.1. Background
There is robust evidence supporting the use of SPECT MPI in the workup and risk stratification
of patients with suspected or known CAD because of its high diagnostic and prognostic value
[27]. The development of solid state detector cameras compared with conventional SPECT
(Anger) cameras offer improved signal resolution and shorter image acquisition time, which
increases laboratory throughput [28, 29]. The switch from the standard, filtered back projection
reconstruction method to iterative algorithms, which include depth independent resolution
recovery, noise regularization, and scatter and attenuation correction, has improved the signal-
to-noise ratio and image quality. This also allows for low-dose imaging using a standard
acquisition time with reduced radiation exposure to the patient and operator,without com‐
promising image quality and accuracy in the detection of CAD [30–32]. This is consistent with
the American Society of Nuclear Cardiology’s goal to reduce the radiation dose to ≤9 mSv in
50% of MPI studies by 2014.
3.2.2. Principles
SPECT MPI uses radionuclide-labeled compounds that emit Y ray photons. SPECT perfusion
radiotracers include 201-Thallium (Tl-201, half-life [t½] = 73 hours), and 99m-Technetium
(99mTc, t ½ = 6 hours)-labeled sestamibi or tetrofosmin. Tl-201 is produced from a cyclotron and
99mTc is produced by a molybdenum-99-99mTc generator.
SPECT MPI can be performed using exercise or pharmacological stressors. Exercise is preferred
for patients who can exercise at an adequate workload, aiming for a minimum of 85% of the
maximal age-predicted HR and 5 METs [33]. A submaximal exercise workload decreases the
sensitivity of exercise SPECT MPI for the detection of CAD. Exercise usually increases MBF
by 2–3 times of resting flow [24, 34].
A pharmacological stressor should be used in patients who are unable to exercise or those with
baseline ECG abnormalities (pre-excitation, paced ventricular rhythm, LBBB). Pharmacologi‐
cal stressors include intravenous vasodilators (adenosine, dipyridamole or regadenoson) or
dobutamine, a β-adrenoceptor agonist. Vasodilators activate the adenosine A2A receptor and
cause coronary arteriolar vasodilatation. Vasodilators increase MBF by 3–5 times in normal
coronary vessels, an increase termed as the coronary flow reserve. Meanwhile, dobutamine
increases MBF similar to that induced by exercise. In the presence of flow limiting stenosis,
the coronary vessel is maximally vasodilated at baseline. Hence, the administration of a
vasodilator is unable to augment coronary flow. MPI assesses the regional flow heterogeneity
in normal and diseased coronary vessels [35]. Generally, vasodilators do not cause myocardial
ischemia because MBF increases, albeit with some variability in all coronary artery beds with
a minimal or no increase in the rate-pressure product, a measure of myocardial oxygen
demand. In patients with extensive CAD, ischemia can be induced by the coronary steal
phenomenon [33]. Vasodilators may also activate other adenosine receptors (A1, A2B, and A3)
resulting in bronchospasm (A2B and, A3) or AV conduction delay (A1). Regadenoson is a
selective A2A receptor agonist that is better than other vasodilators in patients with moderate
chronic obstructive pulmonary disease (COPD) or asthma [36, 37].
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For pharmacological stress SPECT MPI, contraindications include asthma or COPD with active
wheezing, 2nd or 3rd degree AV block without a pacemaker or sick sinus syndrome, systolic BP
<90 mmHg, use of methylxantines (e.g., aminophylline or caffeine) <12 hours, known hypersen‐
sivity to the vasodilator, acute myocardial infarction (MI) and acute coronary syndrome [33].
3.2.3. Diagnostic and prognostic accuracy
The diagnostic accuracy of all noninvasive tests is subject to the post-test referral bias, also
known as the verification bias. This increases the sensitivity and reduces the specificity of the
test. A normalcy rate is used as a surrogate for specificity. It is defined as the percentage of
normal perfusion scans in patients with a low likelihood (<10%) of CAD based on the results
of clinical and ECG stress tests [38–40]. A pooled analysis of 4,480 patients with known or
suspected CAD showed that exercise SPECT MPI had a mean sensitivity of 87% and a
specificity of 73% for the detection of >50% stenosis [41]. The normalcy rate of SPECT MPI is
around 84% [38]. Standard MPI studies include a combination of stress and rest protocols. The
use of a stress-only protocol with a “normal” stress study can reduce the radiation dose by
40% and detected similar event rates [42–44]. A “normal” stress-only study is defined as
homogenous perfusion, summed stress score (SSS) of <3, normal left ventricular (LV) cavity
size, function, and wall motion [43].
The prognostic value of a normal pharmacological stress MPI test is independent of the
radiopharmaceutical used [45]. A meta-analysis of 19 SPECT MPI studies comprising 39,000
patients demonstrated a low annual event rate of 0.6%, for hard cardiac events such as cardiac
death or nonfatal MI in patients with a normal test result [46]. However, the prognostic value
is based on the studied population. For example, the annual event rate among individuals with
a normal test result was higher among diabetic patients than in non-diabetic subjects (0.5% vs.
1.7%, respectively, p < 0.005). Diabetic patients with a LV ejection fraction (LVEF) of ≤ 45% had
the worst outcome [47]. High-risk MPI variables include large perfusion defect size and extent,
transient ischemic dilatation (TID), post stress stunning, increased right ventricular uptake,
and increased lung uptake especially with Tl-201. A normal perfusion on exercise SPECT MPI
was associated with a low event rate (<1% per year) in subjects with a low or intermediate DTS,
compared in subjects with an intermediate DTS and high-risk SPECT variables or those with
a high DTS and a normal perfusion [48].
3.2.4. Strengths and limitations
The strengths and limitations of SPECT using 99mTc-labeled sestamibi or tetrofosmin are shown
in Table 6.
3.2.5. Case example 2
A 60-year-old female with hypertension presented with atypical chest pain. Pre-test probabil‐
ity of CAD is intermediate. Pharmacological (dipyridamole) SPECT MPI was performed due
to an uninterpretable resting ECG that showed a LBBB. The test is considered appropriate
based on the AUC. SPECT MPI demonstrated normal perfusion (Figure 2).
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Figure 2. Stress (top row) & Rest (bottom row) images in the short axis (SA), horizontal long axis (HLA) and vertical
long axis (VLA) show normal homogenous tracer uptake. Gated images showed normal left ventricular ejection frac‐
tion (not shown). This is a normal SPECT MPI study.
Strengths Limitations
Widely available Low specificity
High sensitivity Lower spatial resolution
Expensive Prone to attenuation artifacts
Well validated Long procedural time (≈4 hrs)
Exercise and pharmacological Longer half life of tracers
stress
Improved specificity with Increase hepatobiliary
gated SPECT uptake
Radiation exposure
Table 6. Strengths and limitations of 99mTc-labelled sestamibi or tetrofosmin SPECT MPI
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3.2.6. Case example 3
A 58-year-old man with a history of hyperlipidemia presented with typical angina (Canadian
Cardiovascular Society Class 2). Pre-test probability of CAD: High. He underwent exercise
SPECT MPI, which is considered an appropriate test based on the AUC. Baseline ECG showed
sinus rhythm (Figure 3A) and resting BP of 140/90 mmHg. At 2 minutes in Bruce protocol, he
developed significant ST-segment depression (Figure 3B). A significant BP drop from 140/90
mmHg to 80/60 mmHg during exercise was present and the test was terminated. The ECG
changes persisted 5:50 minutes into recovery, and BP gradually returned to baseline. He
achieved a total of 5 METS. He remained asymptomatic of chest pain. Calculated DTS was -17
(high risk). SPECT MPI findings as described in Figure 3C. He was referred for ICA (Figure 3D).
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Figure 3. (a) Resting ECG showed normal sinus rhythm (b) ECG showed 3 mm ST segment depression in leads 1, aVF
and V3, and a maximum of 4 mm ST segment depression leads II, V4 to V6. (c) Stress (top row), Rest (bottom row) in
the SA slices: Mild reduction in tracer uptake in the mid to distal anterolateral walls (arrow) which normalized at rest.
This was consistent with mild ischemia in the left circumflex (LCX) artery/ left anterior descending artery territory
(LAD). TID is defined as the ratio of ungated LV volumes at stress and rest was present (1.21). TID is due to extensive
subendocardial ischemia post stress that resolves on the rest images. ICA showed distal left main 90%, ostial LAD 90%,
first diagonal 90%, first obtuse marginal 100%, second obtuse marginal 100%, right coronary artery 100%, and subse‐
quently referred for CABG. This example clearly illustrates, despite a mildly abnormal perfusion (i.e. mild reduction in
myocardial tracer uptake), the associated presence of high risk variables such as TID, and a high DTS, identifies a high
risk scan. (d) Significant stenosis in the ostial LAD (orange arrow) and occluded proximal RCA with diffuse disease
(purple arrows).
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4. Clinical pearls
1. Combination of low-level exercise with dipyridamole can improve image quality and
reduce symptoms resulting from drug effects.
2. High-risk findings include large defect size and extent, TID, post-stress stunning,
increased right ventricular uptake, and increased lung uptake.
3. The prognosis of a normal MPI study is dependent on the study population.
4. A normal SPECT perfusion scan with ischemic ECG changes during vasodilator stress is
associated with a significant cardiac event rate (~2% per year) and should be followed up
with further cardiac imaging (PET MPI or CCTA).
5. Avoid antianginal medications such as beta-blockers, calcium channel blockers, or nitrates
at least 48 hours prior to stress MPI for ischemia detection in suspected CAD.
4.1. Positron emission tomography
4.1.1. Background
PET MPI has superior temporal and spatial resolution, greater count sensitivity, and accurate
attenuation correction compared with SPECT. These features translate into greater diagnostic
image quality with fewer equivocal results, especially in obese subjects for example [49, 50].
The latest generation of PET cameras are combined with CT usually with ≥16 slices, and
provide 3-dimensional imaging. Integrated PET (emission scan)/CT (transmission scan)
systems facilitate sequential scanning, faster acquisition of transmission images, and enable
functional and anatomic assessments in a single study [51–53]. These features make PET a
useful clinical choice, but widespread utilization is limited by cost.
4.1.2. Principles
PET imaging is based on the detection of positron emission from radionuclide decay. After
emission, the positron travels a short distance before it collides with an electron, resulting in
mutual annihilation. This annihilation results in the production of 2 Y photons of 511 keV that
travel in nearly opposite directions. The simultaneous detection of both photons by the detector
of a PET camera is called coincidence detection [51–53].
Examples of cardiac PET radiotracers include rubidium-82 (82Rb; t½ = 76 s), nitrogen-13ammonia (13N- Ammonia; t½ = 9.96 min), and oxygen-15 water (15O-H2O; t ½ = 2 min). A shortert½ allows a lower radiation dose per test. Radiotracers are produced by a cyclotron, except for
82Rb, which is eluted from a strontium-82 (82Sr)/82Rb generator.
Ischemia is detected in the same way as for SPECT MPI. The fundamental difference in uptake
kinetics of radiotracers used in SPECT and PET explain the superior sensitivity of PET for the
detection of CAD. The ideal radiotracer is 15O-H2O, which has linear uptake by myocardialtissue with increasing blood flow and “no roll-off” phenomenon. 99mTc- labeled tracers have a
much lower extraction fraction. At high MBF, 99mTc- labeled tracers are characterized by a roll-
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off phenomenon to a greater degree, unlike PET radiotracers [54]. At high MBF levels during
stress, the relative difference in myocardial tracer uptake may be reduced leading to an
underestimation of the regional flow heterogeneity between normal and diseased coronary
arteries. With dynamic imaging of the tracer kinetics in PET MPI, it is feasible to measure the
myocardial flow reserve (MFR), which is defined as the ratio of absolute MBF during stress
compared to MBF at rest. An abnormal global MFR is indicative of diffuse atherosclerosis or
microvascular dysfunction.
4.1.3. Diagnostic and prognostic accuracy
PET MPI showed superior sensitivity and diagnostic accuracy, compared to SPECT [55, 56].
A meta-analysis of three different stress perfusion modalities determined the pooled sensitiv‐
ity, specificity, and area under the curve of SPECT (88%, 61%, and 0.86, respectively), CMR
(89%, 76%, and 0.90, respectively) and PET (84%, 81%, and 0.92, respectively) for the detection
of CAD [57].
PET MPI can be used to determine prognosis, revealing annual event rates for cardiac death
and nonfatal MI of 0.4%, 2.3%, and 7.0% for SSS values of <4 (normal), 4–7, and >8, respectively
[58]. A similar trend was noted when subjects were stratified according to the percentage of
ischemic LV myocardium, with a relative hazard for cardiac death of 2.3%, 4.2%, and 4.9% for
the strata of 0.1–9.9%, 10–19.9%, and ≥ 20%, respectively [59]. Parameters that measure the
extent of ischemia have been shown to guide the decisions regarding revascularization [60].
An abnormal global MFR (<2.0) was associated with an increased incidence of MACE com‐
pared with a normal MFR (1.3% vs. 4.7%, p = 0.03), independent of a normal perfusion and a
CS of 0 [61].
4.1.4. Strengths and limitations
The strengths and limitations of PET MPI are shown in Table 7.
Strengths Limitations
High spatial resolution Expensive
Robust attenuation correction Not widely available
Improved diagnostic Radiation exposure
accuracy in the obese
Alternative for an equivocal Unable to assess exercise capacity
SPECT study
Short half life of tracers Pharmacological stress
Absolute MBF
Assessment of calcium on CT
Table 7. Strengths and limitations of PET MPI
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4.1.5. Case example 4
A 68-year-old female with obesity, hypertension and an ex-smoker presented with chest pain.
Noncontrast CT showed a CS of 715. CCTA was not performed. A persantine 82Rb PET MPI
was performed (Figure 4A) and gated images were acquired at stress and rest (Figure 4B).
Coronary calcium was visualised on CT and MBF was abnormal (Figure 4C).
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Figure 4. (a) Following stress, there is mild to moderate reduction in tracer uptake in the apical (distal) segments of the
septum and anterior wall, and apex, which predominantly improves at the rest. This is consistent with a moderate
sized area of moderate ischemia in the distal LAD territory. Stress images (rows 1, 3, and 5) and rest images (rows 2, 4,
and 6). (b) Gated stress (top 3 rows) and gated rest (bottom 3 rows) during PET MPI. Normal LVEF and wall motion at
rest. Following stress, there is mild hypokinesis in the apical (distal) septum and apex consistent with stress induced
ischemia (red arrows). Stress acquisition during PET MPI is acquired at peak stress, and hence presence of regional
wall motion is specific for ischemia. This differs from post-stress acquisition during SPECT which is delayed by 30 to
45 minutes. (c) Polar map shows the extent of reversible ischemia in the LAD territory (red arrow). CT shows presence
of coronary calcification in the RCA (top, blue arrow), LCX and LAD (bottom, blue arrow). MBF demonstrate marked
reduction in stress flow in the areas of reduced perfusion (global MBF= 0.74 ml/min/g), as depicted by the polar map
which is labelled as stress Rubidium. Global MFR is reduced at 1.16, and 0.99 (after correction for RPP). There is re‐
duced regional MFR in all three coronary artery territories (LAD= 0.98, LCX= 1.38, and RCA= 1.24), as seen on the polar
map labelled as Reserve. The MFR finding is suggestive of underlying triple vessel disease. Measurement of MBF is
corrected for rate-pressure product (RPP), and depicted in the shade of gray, next to the uncorrected values.
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4.1.6. Clinical pearls
1. PET imaging is based on positron annihilation and coincidence detection of paired 511
keV Y photons.
2. PET has higher diagnostic accuracy compared to SPECT in the assessment of obstructive
CAD.
3. PET is an excellent choice for imaging in the obese and those with an equivocal SPECT.
4. Abnormal global MFR suggest diffuse atherosclerosis or microvascular dysfunction.
5. Patient motion can result in significant misregistration artifact between the emission and
transmission scans.
6. Normal PET perfusion and MFR confer an excellent prognosis.
4.2. Stress echocardiography
4.2.1. Background
SE is a robust, versatile imaging modality for CAD assessment. Advances in digital image
acquisition, strain imaging, tissue harmonics, and contrast agents have increased the use of
SE. In particular, the advances in tissue harmonics and contrast agents have greatly improved
the visualization of endocardial borders, and diagnostic accuracy of SE for the detection of
wall motion abnormalities (WMA) [62–64]. Because SE is highly operator- dependent, those
who perform the test should have adequate training and experience to meet the level of
competency required for performing and interpreting this test [65].
4.2.2. Principles
The fundamental principle for the detection of myocardial ischemia is the development of new
or worsening WMA during stress [65, 66]. Based on the ischemic cascade, WMA appear after
perfusion abnormalities and precede the manifestation of ECG changes and symptoms. Thus,
SE has decreased sensitivity and superior specificity compared to perfusion-based imaging for
the detection of CAD. Images are acquired at rest and stress. The images are compared on a
four-screen setup side-by-side for WMA, LV cavity size and LVEF.
The stress component may be exercise (treadmill or bicycle) or pharmacologically (dobutamine
or dipyridamole). An adequate level of stress using exercise requires a minimum target of 85%
of the age-predicted HR, and is preferably symptom-limiting, considering the additional
prognostic value of the subject’s exercise capacity. Bicycle SE (supine or upright ergometry)
allows simultaneous image acquisition during peak stress, and the measurement of Doppler
information. During treadmill exercise SE, the stress images are acquired within 60–90 seconds
post stress. The contraindications and indications for terminating an exercise SE are similar to
those of exercise ECG.
Pharmacological SE using dobutamine is preferred over dipyridamole for wall motion
assessment [65], although either stressor can be used [67]. The dose for dipyridamole in SE is
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higher at 0.84 mg/kg over 10 minutes, compared to the dose used in nuclear perfusion imaging
at 0.14 mg/kg/min over 4 minutes. A typical dobutamine infusion rate is at 5 micrograms/kg/
min and increasing at a 3-minute interval to 10, 20, 30, and 40 micrograms/kg/min, aiming to
achieve 85% of the age-predicted target HR. Atropine can be used to achieve the desired target
HR. The induction of ischemia is due to an increase in myocardial oxygen demand. Deforma‐
tion analysis using the tissue velocity index (TVI) and two-dimensional speckle tracking (ST)-
based strain imaging have been proposed using dobutamine SE [68, 69]. However, TVI- and
ST-based analysis conferred no additional diagnostic value over WMA for detection of
ischemia [70].
Indications for terminating the test include the de novo or worsening of WMA, significant
arrhythmias, hypotension, severe hypertension, and intolerable symptoms. For image
interpretation, normal wall motion is defined as normal wall thickening and endocardial
excursion. Visual assessment of wall motion can be categorized and scored as follows: 1 =
normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic or aneursymal. Please note that a score of
“5” is no longer applicable. Each segment using the 16 segment LV model (i.e., apical cap not
included) is scored and the wall motion score index (WMSI) is calculated. A normal WMSI
equals to “1”. WMSI = Total wall motion score/ Total number segments visualised. Unlike in
MPI that utilizes the 17 segment model, for WMA assessment the 16 segment model is
preferred. A WMSI of >1.7 corresponds to a perfusion defect of >20% on MPI. If feasible, the
right ventricular wall motion should be assessed and presence of WMA suggest greater extent
of CAD.
Normal: normal at rest; hyperdynamic at stress
Ischemia: normal at rest; inducible new or worsening WMA (hypokinesis, akinesis or dyski‐
nesis) at stress
Infarction: fixed abnormality at rest and stress
4.2.3. Diagnostic and prognostic accuracy
The development of WMA depends on the extent of stenosis detected by ICA, and occurs at a
cut-off relative diameter of 54% for exercise SE, 58% for dobutamine SE, and 60% for dipyri‐
damole SE [71]. The sensitivities and specificities for the detection of CAD were 85% and 77%,
respectively, for exercise SE, 80% and 86%, respectively for dobutamine SE, and 78% and 91%,
respectively, for dipyridamole SE [71, 72]. SE had a similar diagnostic accuracy to that of SPECT
MPI for the detection of CAD [73, 74]. However, because of its greater specificity, SE showed
a better discriminatory capacity for the diagnosis of LM and TVD [75]. For patients presenting
at an emergency department with chest pain, nondiagnostic ECG, and negative cardiac
biomarkers, the overall sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV) of SE for the diagnosis of CAD were 90%, 92%, 78% and 97%, respec‐
tively. Moreover, exercise SE had a better specificity than dobutamine SE [76].
A normal exercise SE result is associated with an excellent prognosis with an annual event rate
of cardiac events of 0.54% [77]. The best discriminator of increased risk of cardiac events was
WMSI ≥ 1.25 and ≤ 6 METs in both genders [78]. There was no difference in the prognostic
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value of dobutamine SE and dipyridamole SE [79, 80]. Therefore, the choice between these
techniques may depend on institutional practices. With regards to LV cavity size, an abnormal
stress LV end-systolic volume (LVESV) (i.e., no change or an increase) was associated with an
increase risk of cardiac events compared with a decrease in the LVESV (2.9% vs. 1.6%) [81].
4.2.4. Strengths and limitations
The strengths and limitations of SE are shown in TABLE 8.
Strengths Limitations
Cheap Poor echo window (obese,
COPD)
Widely available Reduced sensitivity in
detection of posterior wall
ischemia
No radiation Foreshortened LV apex
Portable Operator dependent
Contrast echo improves
endocardial definition
Exercise and pharmacological
stress
Medium procedural time
Table 8. Strengths and limitations of stress echocardiography
4.2.5. Case example 5
65-year-old woman with rheumatoid arthritis and hypertension presented with heartburn and
indigestion of increasing severity for 1 month. An exercise SE with contrast was performed at
rest. She experienced a similar episode of heartburn and nausea at 2 minutes into exercise. The
test was stopped and stress images were acquired immediately (Figure 5A). Rest and stress
images are shown as still frames captured at end-systole (Figure 5B i-iv). The patient was
admitted in view of a positive SE at low workload. ICA showed ostial LAD 70%, mid LAD
90%, proximal LCX 80%, and mid RCA 100%. She was referred for CABG.
4.2.6. Clinical pearls
1. Normal wall motion at rest does not rule out the presence of obstructive CAD.
2. Abnormal regional wall motion can be seen in the presence of ischemic or nonischemic
etiology.
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Figure 5. (a) ECG during episode of chest pain demonstrated diffuse 2 mm ST segment depression in leads II, III, aVF,
V2 to V6 and ST elevation in aVR. (b) SE using contrast showing images captured at end-systole during rest and stress.
The LV in different views are illustrated in the following sequence from top to bottom (i) parasternal long axis, (ii) 2-
chamber, (iii) short axis, (iv) apical, demonstrate regional WMA in the anterior, anteroseptum, apex and lateral walls.
Note the stress induced LV cavity dilatation, at peak stress which is suggestive of underlying triple vessel disease.
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3. The absence of radial motion of the mitral valve annulus can result in a reduction in motion
of the basal inferior or inferoseptal segments resulting in a false-positive study.
4. A common cause of a false negative test is a suboptimal stress level.
4.3. Coronary computed tomography angiography
4.3.1. Background
CCTA has come a long way from electron beam CT to the present multidetector CT system,
with continually increasing detector rows (i.e., = slices) from 4-slices to 320-slices in some
systems. A 64-slice CT system is the minimum requirement for coronary imaging. Other
developments include iterative reconstruction, dual-source CT, prospective scanning, tube
current modulation, and a z-flying focal spot [82]. These innovations have led to significant
improvements in spatial and temporal resolution, radiation dosimetry, and image quality,
which are prerequisites for coronary imaging. The ability to visualize subclinical atheroscle‐
rosis and characterize plaques has led to techniques for quantifying the extent of the athero‐
sclerotic burden [83].
4.3.2. Principles
CCTA can determine the extent of coronary atherosclerosis and estimate the severity of
coronary artery stenosis. The major components of a CT scanner include the table, X-ray tube,
detector array and the gantry that rotates the X-ray tube and detector array around the patient.
The ability to image a beating heart requires a high temporal resolution, which is defined as
the time taken to obtain a complete data set for image reconstruction. The typical temporal
resolution of CT is 280–420 ms. Data covering 180° are needed to construct one image, termed
“half scan reconstruction”. Accordingly, the temporal resolution of a single-source CT system
is half the time required for the gantry to rotate 360°. For a dual-source CT (DSCT), the temporal
resolution is one-quarter of the gantry rotation time, because data covering 90° are sufficient
for image acquisition. A DSCT has a temporal resolution of 75 ms (compared to 20–30 ms for
ICA) [84].
The ability for CT to discriminate two structures is called the spatial resolution, which is
measured in line pairs per centimeter (lp/cm). The typical spatial resolution of CT is 10 lp/cm,
which is equivalent to 0.5 mm (compared to 0.1 mm for ICA). CT data are acquired as isotropic
voxels enabling the images to be viewed in multiple planes with similar spatial resolutions
[85]. The spatial resolution of CT is less than ideal to accurately quantitate the degree of
stenosis, hence a grading method is used [86]:
Normal: 0%; Minimal: <25%; Mild: 25–49%; Moderate: 50–69%; Severe: 70–99%; Occluded:
100%.
ECG gating is essential to minimize cardiac motion by synchronizing image acquisition to the
cardiac cycle. There are two types of scanning modes. In prospective ECG-triggered scanning,
data acquisition is triggered by the R waves on the ECG. Its advantage is the low radiation
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dose, typically 3–5 mSv. Disadvantages include image reconstruction limited to the desired
phase and functional evaluation is not possible. In retrospective ECG-gated scanning, data
acquisition are acquired throughout the cardiac cycle and the ECG signal is simultaneously
recorded with the raw data. Advantages include image reconstruction can be performed at
any point in the cardiac cycle and it is useful in patients with arrhythmias. Its main disad‐
vantage is the high radiation dose, typically 10–12 mSv because the tube current remains “on”
throughout image acquisition. The application of tube current modulation can reduce the
radiation dose. The best phase for image acquisition is mid-diastole, when the heart is moving
the least.
The images to be acquired are the initial scout image, which defines the scan length, followed
by a non-contrast calcium scan and finally the contrast-enhanced CT images. The average scan
length for native coronary artery imaging is 12–14 cm. Using a 64-slice scanner, images are
acquired over a few cardiac cycles, as opposed to a 320-slice scanner where one cardiac cycle
is sufficient because of the larger volume covered. Data can be reconstructed in two or three
dimensions, although the two-dimensional axial views should serve as a reference for image
interpretation.
Contrast enhancement in the ascending aorta can be tracked using a test bolus or automated
bolus tracking. Both methods are acceptable and the choice between them may depend on the
institutional protocol. About 80–100 ml of iodinated contrast is typically used. The target HR
of 50–65 bpm can be achieved by oral or intravenous β-adrenoceptor blockers. Nitroglycerin
spray is recommended to improve image quality by inducing coronary vasodilatation.
Calcium is measured using the Agatston score (i.e., CS), which correlates with the extent of
the atherosclerotic plaque burden. Screening for CS are recommended in two groups of
asymptomatic patients: (1) patients with low global coronary heart disease (CHD) risk and a
family history of premature CAD and (2) patients with intermediate global CHD risk [87]. CT
perfusion is still research-based, and will not be discussed in this review.
4.3.3. Diagnostic and prognostic accuracy
There is extensive literature describing the diagnostic and prognostic value of CCTA. The main
advantage of CCTA is the ability to exclude disease from the differential diagnosis since CCTA
has an excellent NPV. The ACCURACY trial demonstrated sensitivity, specificity, PPV, and
NPV of 95%, 83%, 64%, and 99%, respectively, for the detection of ≥ 50% stenosis, and 94%,
83%, 48%, and 99%, respectively, for the detection of ≥70% stenosis. The NPV was high in
patient- and vessel-level analyses [88]. The low PPV is due to its tendency to overestimate
stenosis, while the presence of artefacts lead may lead to a false positive test. CCTA is
considered appropriate for patients with low or intermediate pre-test probabilities of CAD,
and a negative scan reliably indicates the absence of significant CAD. However, CCTA is of
limited clinical value and functional imaging tests are more appropriate in patients with a high
pre-test probability [89]. The presence of severe coronary calcification (CS >400) can reduce the
diagnostic accuracy by overestimating the severity of stenosis owing to blooming artefacts [88].
Although there is no specific cut-off level to cancel a CCTA, CS of > 600–1000 is typically used
for this purpose, considering the high likelihood of a nondiagnostic study.
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The use of CCTA in the emergency department resulted in a shorter hospital stay, increased
discharge rate [90, 91], and reduced time to CAD diagnosis [90], while patients with a negative
scan had an excellent prognosis [92]. The all-cause mortality rate was 0.65% for normal CCTA,
1.99% for <50% stenosis, 2.9% for ≥50% stenosis, and 4.95% for LM ≥50%, TVD ≥70%, or two
vessel disease with proximal LAD disease [93]. The excellent prognosis of a negative CCTA
result was seen in other large series of patients [94]. The “warranty period” of a normal CCTA
is ~7 years [95]. Coronary calcium has prognostic value beyond traditional risk factors with a
hazard ratio of 3.89, 7.08, and 6.84 for CS of 1–100, 101–300, and ≥300, respectively, for coronary
events [96].
4.3.4. Strengths and limitations
The strengths and limitations of CCTA are shown in Table 9.
Strengths Limitations
Excellent negative predictive High calcium limits accuracy
value of assessing stenosis
High temporal resolution Radiation exposure
High spatial resolution Morbidly obese
Visualize coronary anatomy Arrhythmias
Short procedural time Allergy to iodinated contrast
Assessment of calcium score Heart rate control
Follow breath hold instruction
Renal impairment (>2.0 mg/dl)
No functional assessment
Table 9. Strengths and limitations of CCTA
4.3.5. Case example 6
A 71-year-old female with hypertension, hyperlipidemia, and an ex- smoker presented with
atypical chest pain and LBBB. CCTA was performed. Findings included a CS of 269, and ≥70%
stenosis (calcified and noncalcified plaque) with positive remodeling in the mid LAD (Figure
6). There was mild disease in ostium of the RCA. She was referred for ICA.
4.3.6. Case example 7
A 57-year-old man with hypertension. CCTA showed a CS of 524 with an occluded proximal
RCA. He was referred for ICA and underwent percutaneous coronary intervention to the RCA
(Figure 7 A-E).
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Figure 7. Axial slices from cranial to caudal demonstrate (A) contrast enhanced lumen in the proximal RCA, (B) absent
of contrast enhancement and (C) reappearance of the contrast in the RCA. (D) Axial maximum intensity projection of
the RCA demonstrate an occluded vessel and correlates with ICA (E).
 
ǃ
RCA 
LAD 
Figure 6. First two images of the curved multiplanar reformatted (MPR) and 2D-axial views demonstrate ≥70% steno‐
sis of the LAD (blue arrows). The third image (curved MPR) of the RCA showing a calcified plaque with minimal
stenosis at the ostium (blue arrow).
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4.3.7. Clinical pearls
1. An asymptomatic patient with a CS of 0 has a very low event rate of 0.1% per year [97].
2. Prospective ECG-triggered acquisition is preferred in view of the lower radiation dose.
3. Regular, low HR and obeying breath-hold instructions are essential for diagnostic image
quality.
4. Appropriate timing of contrast injection is crucial for optimal enhancement as contrast
non-uniformity in the distal coronary vessels can simulate stenoses.
5. Volume coverage in the z-axis for a 64-slice CT (0.625 mm detector width) is 4 cm (64 x
0.625), and a 320-slice CT (0.5 mm detector width) is 16 cm.
4.4. Stress cardiac magnetic resonance
4.4.1. Background
CMR has recently emerged clinically as a highly versatile technique with superior spatial and
temporal resolution. The development of high field strength magnets (3T) and rapid imaging
techniques such as gradient echo, echo-planar, and balanced steady-state free precession, have
contributed to the feasibility of MR perfusion. The type of pulse sequence or hybrid sequences
affect the contrast-to-noise ratio and the suspectibility to artifacts, which can affect image
quality. In the context of MPI, CMR is a promising tool in parallel with well-established and
validated modalities such as SPECT and PET MPI. The advantage of MR is its superior
sensitivity for the detection of subendocardial perfusion defects without radiation exposure.
The paramagnetic property of gadolinium (Gd)-based contrast agents can alter the local
magnetic field in the tissue, which enables differentiation between normally and abnormally
perfused myocardium. Arterial spin labeling and blood oxygen level-dependent techniques
are new advances in perfusion imaging, but are still research-based. The use of coronary
magnetic resonance angiography is not well established, except in some highly specialized
centers, and will not be discussed here.
4.4.2. Principles
The fundamental basis of CMR perfusion imaging is the first-pass imaging of contrast transit
through the LV myocardium. This exploits the effect of Gd on the T1 relaxation time of
myocardial tissue [98]. Gd-based contrast agents are paramagnetic, extracellular agents that
are rapidly taken up and rapidly washed out of the normal myocardium, but accumulate in
damaged tissues with slower washout kinetics. Gd is highly toxic in its native state. Therefore,
Gd chelators (e.g., Gd-DTPA) are used clinically. These agents shorten the T1 and T2 relaxation
time constants that represent the decay of the MR signal. However, at low doses, T1 shortening
is predominant. During first-pass perfusion, the normal myocardium (i.e., normal perfusion)
shows substantial Gd uptake, and appears bright (i.e., hyperintense) owing to a short T1.
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Ischemic myocardium (i.e., reduced perfusion) shows diminished Gd uptake and appears dark
(i.e., hypointense) owing to a long T1 [98].
Similar to pharmacological stress SPECT or PET MPI, stress CMR requires the use of a
pharmacological stressor, such as a vasodilator (e.g., adenosine, dipyridamole, and regade‐
noson) or dobutamine. Diseased coronary arteries, exhibit a lower peak myocardial signal
intensity and increases in myocardial contrast transit time (e.g., signal upslope, arrival time,
time-to-peak signal, and mean transit time)[99]. The difference in signal intensity can be
quantitatively, semiquantitatively, or visually evaluated to identify possible perfusion defects.
The use of adenosine and visual interpretation are common, and these approaches are
discussed in further detail.
Historically, inducible ischemia was only assessed using stress and rest perfusion cine images.
This method demonstrated a sensitivity, specificity, and diagnostic accuracy of 88%, 90%, and
89%, respectively, for the detection of significant CAD [100]. The caveat being, in patients with
prior MI, the resultant perfusion deficit may include areas of prior infarct and may not reflect
true inducible ischemia. Imaging with late Gd-enhancement (LGE) was used to detect prior
infarction. A method combining first-pass stress and rest imaging with LGE demonstrated an
overall accuracy of 0.88, or 0.96 for one-vessel disease, 0.75 for two-vessel disease, and 0.9 for
prior coronary artery bypass graft, in the detection of significant stenosis [101].
A stress CMR study can be interpreted using the following algorithm [99]:
Step 1. Assess for LGE
Negative: Move to step 2.
Positive: CAD present.
Step 2. Assess stress perfusion
Negative: No CAD
Positive: Move to step 3.
Step 3. Assess rest perfusion
Negative: Inducible ischemia suggestive of CAD.
Positive: Likely artifact*
* Common being the Gibbs artifact, which is more pronounced on a 3T scanner. This usually
occurs in the phase encoding direction and tends to be transient. If the segment of perfusion
defect is also positive for LGE, then inducible ischemia cannot be assessed in the same segment.
An abbreviated adenosine stress CMR protocol [102]:
1. LV structure and function module – scout and cine imaging for cardiac structure and
systolic function at rest.
2. First pass stress perfusion module – infusion of adenosine (140 mcg/kg/min over 4
minutes), followed by intravenous Gd (0.05 to 0.1 mmol/kg) and saline flush. Once the
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contrast bolus has transited the LV myocardium, adenosine is stopped. Stress images are
acquired for 40 to 50 heart beats.
3. Rest perfusion module– performed after 10 minutes to ensure sufficient clearing of Gd
from the blood pool. Reinjection of a second dose of Gd. Rest images are acquired. Slice
geometry, scan setting, and Gd dose should be similar to step (2).
4. LGE module– performed after 5 minutes of completion of step (3).
5. Analysis– visual interpretation using the 17 segment LV model. The stress and rest cine
images are viewed side-by-side using equivalent slices, in addition to the LGE images.
(Some centers omit the rest perfusion module, if the first pass stress perfusion study is normal).
Adenosine (t ½ = 10 s) is safe and well-tolerated. The potential adverse effects include flushing,
chest pain, palpitations, breathlessness, transient episodes of heart block, hypotension, sinus
bradycardia, and bronchospasm [102]. The contraindication to adenosine stress CMR (in
addition to the general contraindication of any MR study) include known hypersensitivity to
adenosine, known or suspected bronchoconstrictive or bronchospastic disease, 2nd or 3rd degree
AV block, sinus bradycardia (HR <45 bpm), and systolic BP <90 mmHg [102].
4.4.3. Diagnostic and prognostic accuracy
Diagnostic accuracy of stress CMR in a population with high prevalence of CAD (57%) showed
on an overall sensitivity of 89% and specificity of 80% for the diagnosis of significant obstruc‐
tive CAD. Adenosine-based stress demonstrated better sensitivity than dipyridamole (90% vs.
86%), but with similar specificity (81% vs. 77%) [103]. Adenosine and dobutamine stress CMR
have similar sensitivity and specificity [104]. Stress CMR showed no difference in diagnostic
accuracy when compared to SPECT MPI for CAD detection [105]. The concordance and
accuracy of stress CMR with 320-detector row CT, showed an excellent agreement (92%, kappa
value = 0.81) in an intermediate risk cohort [106]. Adenosine perfusion was the most accurate
component of the stress CMR study in predicting which patients had significant CAD,
compared with resting WMA and LGE [107].
Negative findings on stress CMR are reassuring and associated with annualized event rates
of 0.4% for MI and 0.3% for cardiovascular death. In patients with inducible ischemia, the
annual event rates for MI and cardiovascular death were 2.6% and 2.8%, respectively. The
concomitant presence of LGE was associated with a worse prognosis [108]. Other predictors
of cardiac events were resting WMA, inducible WMA and LGE. Patients with inducible WMA
(i.e., ischemia) experienced significant benefits from revascularization, compared with patients
without inducible WMA (i.e., without ischemia) [109].
4.4.4. Strengths and limitations
The strengths and limitations of stress CMR are shown in Table 10.
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Strengths Limitations
Good contrast resolution Expensive
No radiation exposure Not widely available
Visualization of subendocardial Cardiac device/metallic
ischemia and scar implant
Transmurality Glomerular filtration rate
of scar <30 mls/min
Procedural time
(~45 minutes)
Allergy to gadolinium
Breath hold instructions
Pharmacological stress
Claustrophobia
Table 10. Strengths and limitations of stress CMR
4.4.5. Case example 8
A 65-year-old man with prior coronary artery bypass surgery presents with chest pain. An
adenosine stress CMR was performed. For study interpretation, follow the steps as described
in the text starting with LGE, stress and rest images. There is inducible inferior wall perfusion
defect with no LGE (Figure 8).
           
Figure 8. Left to right: 1st image: LV short axis LGE image show no evidence of scar. 2nd image: Stress first pass perfu‐
sion image demonstrate an inducible inferior wall perfusion defect. 3rd image: The corresponding rest image demon‐
strate no perfusion defect in the inferior wall.
4.4.6. Clinical pearls
1. Avoid caffeinated food and beverages, theophylline, and dipyridamole for 24 hours prior
to stress CMR.
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2. Stress CMR should be avoided in patients with a glomerular filtration rate (GFR) < 30 mls/
min.
3. The presence of infarction on LGE (subendocardial or transmural in a coronary artery
distribution) favors CAD, irrespective of perfusion findings.
4. Criteria for a perfusion defect is a persistent delay in enhancement pattern during first
pass observed in at least 3 consecutive temporal images.
5. Perfusion defects should be graded according to transmurality.
6. Dark-rim artifact typically appear as dark lines at the blood pool-myocardium interface,
and can mimic a perfusion defect (typically Gibbs artifact).
We have come to the end of our review on the essentials of noninvasive imaging modalities
for the assessment of CAD. A proposed algorithm for test selection in suspected CAD is
included (Figure 9). The following are four clinical scenarios commonly encountered in clinical
practice and the suggested answers:
1. Would you perform a test in an asymptomatic 35-year-old woman who plans to partici‐
pate in a marathon next month? She has a normal resting ECG with no cardiovascular risk
factor.
Answer: No. Asymptomatic patients generally do not warrant cardiac testing. Her pretest
probability of CAD is very low (<5%).
2. What is the next suitable test in a 60-year-old woman with morbid obesity who presents
with chest pain? She completed 4 METs and achieved 70% of the maximum age-predicted
HR following an exercise ECG.
Answer: Inability to achieve an adequate stress level reduces the sensitivity of an exercise ECG.
Her pretest probability of CAD is intermediate. In the presence of morbid obesity, PET MPI
or CCTA would be considered a suitable alternative.
3. What test would you perform in a 75-year-old man with a sedentary lifestyle who presents
with chest pain on exertion that is relieved with nitroglycerin spray? He has underlying
COPD, diabetes, and hypertension. Baseline creatinine is 300 micromol/l.
Answer: Pretest probability for CAD is high (≥90%) and the diagnosis of CAD is not in question.
He has stable angina. First step would be to inititate medications such as aspirin, beta-blockers,
calcium channel blockers, and statin therapy. Pharmacological SPECT or PET MPI for risk
stratification is reasonable. Pharmacological SE can be performed if a good echo window can
be obtained. In the presence of moderate ischemic burden, high risk variables on MPI, or
worsening of symptom despite on optimal medical therapy, ICA is warranted.
4. Would you repeat another CCTA in a 50-year-old man with an active lifestyle presenting
with atypical chest pain? He had a calcium score of 0 and a normal CCTA a year ago.
Answer: No. No testing is required. If symptoms persist, consider an exercise ECG.
Coronary Artery Disease - Assessment, Surgery, Prevention62

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(Symptomatic,nonͲAcuteCoronarySyndromepresentation)
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ECG= electrocardiography; CCTA= coronary computed tomography angiography; MPI= myocardial perfusion imag‐
ing; CMR= cardiac magnetic resonance; BMI= body mass index. * BMI ≥30 kg/m2: PET MPI is preferred; BMI <30 kg/m2:
SPECT or PET MPI, depending on resource.
Patients with renal impairment (Creatinine >2.0 mg/dl, avoid CCTA; if GFR <30 mls/min, stress CMR is contraindicat‐
ed.
For pharmacological MPI, use of low level exercise (1.7 mph, grade 0) is an option, in the absence of LBBB.
Figure 9. Proposed algorithm for test selection in suspected coronary artery disease.
5. Conclusion
Understanding the merits and limitations of each noninvasive imaging modality, together with
local expertise and resources, will increase the clinician’s confidence in selecting imaging tests
for the assessment of CAD. This is crucial to avoid layered testing, unnecessary radiation
exposure, and maintain a cost-effective approach. Functional and anatomical noninvasive tests
are associated with similar cardiovascular outcomes in patients with low to intermediate risk
[110]. The use of stress MPI to serve as a gatekeeper for ICA is well validated [111]. A detailed
history and physical examination with sound clinical judgement and the integration of
evidence-based guidelines are vital for selecting the right test. In summary, noninvasive tests
are the cornerstone of CAD assessment. Although not covered in this chapter, such tests also
serve as a guide for ischemia-driven ICA strategies.
6. Conflict of interest
The authors have no conflict of interest to disclose pertaining to the contents of this book
chapter.
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
63
Acknowledgements
All images used in this chapter were obtained from the University of Ottawa Heart Institute.
Author details
Punitha Arasaratnam1,2 and Terrence D. Ruddy1*
*Address all correspondence to: TRuddy@ottawaheart.ca
1 University of Ottawa Heart Institute, Ottawa, Canada
2 Ng Teng Fong General Hospital, Singapore
References
[1] Shaw L, Marwick T, et al. Why all the focus on cardiac imaging? J Am Coll Cardiol
Img. 2010;3(7):789-794.
[2] Wolk, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/ SCCT/ SCMR/ STS, 2013
Multimodality appropriate use criteria for the detection and risk assessment of stable
ischemic heart disease. A Report of the American College of Cardiology Foundation
Appropriate Use Criteria Task Force, American Heart Association, American Society
of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society
of America, Heart Rhythm Society, Society for Cardiovascular Angiography and In‐
terventions, Society of Cardiovascular Computed Tomography, Society for Cardio‐
vascular Magnetic Resonance, and Society of Thoracic Surgeons. JACC 2014; Vol. 63,
No. 4, 2014.
[3] Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Car‐
diol. 1983;1:574-5.
[4] Weintraub WS, Madeira SW, et al. Critical analysis of the application of Bayes’ theo‐
rem to sequential testing in the noninvasive diagnosis of coronary artery disease. Am
J Cardiol. 1984;54(1):43-9.
[5] Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis
of coronary artery disease. N Engl J Med. 1979:300:1350-8.
[6] Shaw L, Mieres J, Hendel R, et al. Effectiveness of exercise electrocardiography with
or without myocardial perfusion single photon emission computed tomography in
women with suspected coronary artery disease. Results form the What Is the Opti‐
Coronary Artery Disease - Assessment, Surgery, Prevention64
mal Method for Ischemia Evaluation in Women (WOMEN) trial. Circulation.
2011;124:1239-1249.
[7] Kohli P, Gulati M. Exercise stress testing in women, going back to the basics. Circula‐
tion. 2010;122:2570-2580.
[8] Okin PM, Bergman G, Kligfield P. Effect of ST segment measurement point on per‐
formance of standard and heart rate-adjusted ST segment criteria for the identifica‐
tion of coronary artery disease. Circulation. 1991;84:57-66.
[9] Fletcher G, Ades P, Kligfield P, et al. Exercise standards for testing and training; A
scientific statement from the American Heart Association. Circulation.
2013;128:873-934.
[10] Desai MY, Crugnale S, Mondeau J, Helin K, Mannting F. Slow upsloping ST-segment
depression during exercise: Does it really signify a positive stress test? Am Heart J.
2002;143:482-487.
[11] Goldschlager N, Selzer A, Cohn K. Treadmill stress tests as indicators of presence
and severity of coronary artery disease. Ann Intern Med. 1976;85:277-286.
[12] Beinart R, Matetzky S, Shechter M, Fefer P, Rozen E, Beinart T, Hod H, Chouraqui P.
Stress-induced ST-segment elevation in patients without prior Q-wave myocardial
infarction. J Electrocardiol. 2008;41:312-317.
[13] Sullivan ID, Davies DW, Sowton E. Submaximal exercise testing early after myocar‐
dial infarction. Difficulty of predicting coronary anatomy and left ventricular per‐
formance. Br Heart J. 1985;53:180-185.
[14] Orsini E, Lattanzi F, Reisenhofer B, Tartarini G. Time-domain analysis of exercise-in‐
duced ST-segment elevation in Q-wave myocardial infarction: A useful tool for the
screening of myocardial viability. Ital Heart J. 2001;2:529-538.
[15] Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assess‐
ment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973;
85:546-562.
[16] Bourque JM, Holland BH, Watson DD, et al. Achieving an exercise workload of ≥ 10
metabolic equivalents predicts a very low risk of inducible ischemia: Does myocar‐
dial perfusion imaging have a role? J Am Coll Cardiol. 2009;54:538-545.
[17] Lauer MS, Francis GS, Okin PM, et al. Impaired chronotropic response to exercise
stress testing as a predictor of mortality. JAMA. 1999;281:524-529.
[18] Vivekananthan DP, Blackstone EH, Pothier CE, et. al. Heart rate recovery after exer‐
cise is a predictor of mortality, independent of the angiographic severity of coronary
disease. J Am Coll Cardiol. 2003;42:83-838.
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
65
[19] Sanmarco ME, Pontius S, Selvester RH. Abnormal blood pressure response and
marked ischemic ST-segment depression as predictors of severe coronary artery dis‐
ease. Circulation. 1980;61:572-578.
[20] Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score
in outpatients with suspected coronary artery disease. N Eng J Med. 1991;325(12):
849-53.
[21] Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the di‐
agnosis of coronary artery disease. A meta-analysis. Circulation. 1989;80:87-98.
[22] Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exer‐
cise testing: summary article: A report of the American College of Cardiology/Ameri‐
can Heart Association Task Force on Practice Guidelines (Committee to Update the
1997 Exercise Testing Guidelines). Circulation. 2002;106:1883-1892.
[23] Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women.
J Am Coll Cardiol. 1998;32:1657-1664.
[24] Mark DB, Hlatky MA, Harrell FE Jr, et al. Exercise treadmill score for predicting
prognosis in coronary artery disease. Ann Intern Med. 1987;106(6):793-800.
[25] Ahmed H, Al-Mallah M, McEvoy J, et al. Maximal exercise testing variables and 10-
year survival: Fitness risk score derivation from the FIT project. Mayo Clin Proc.
2015;90(3):346-55.
[26] Chang SM, Nabi F, Xu J, et al. Value of CACS compared with ett and myocardial per‐
fusion imaging for predicting long-term cardiac outcome in asymptomatic and
symptomatic patients at low risk for coronary disease: Clinical implications in a mul‐
timodality imaging world. J Am Coll Cardiol Img. 2015;8(2):134-44.
[27] Klocke FJ, Baird MG, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac
radionuclide imaging- executive summary: A report of the American College of Car‐
diology/ American Heart Association Task Force on practice guidelines (ACC/AHA/
ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionu‐
clide imaging). J Am Coll Cardiol. 2003;42:1318-33.
[28] Patton J, Sandler M, et al. D-SPECT: A new solid state camera for high speed molecu‐
lar imaging. J Nucl Med. 2006;47:189.
[29] Patton J, Slomka PJ, et al. Recent technologic advances in nuclear cardiology. J Nucl
Cardiol. 2007;14:501-13.
[30] Marcassa C, Campini R, et al. Wide beam reconstruction for half-dose or half-time
gated SPECT acquisitions: Optimization of resources and reduction in radiation ex‐
posure. Eur J Nucl Med Mol Imaging. 2011;38:499-508.
Coronary Artery Disease - Assessment, Surgery, Prevention66
[31] Envoldsen LH, Menashi CAK, et al. Effects of acquisition time and reconstruction al‐
gorithm on image quality, quantitative parameters, and clinical interpretation of my‐
ocardial perfusion imaging. J Nucl Cardiol 2013. doi:10.1007/s12350-013-97752.
[32] Patil H, Bateman T, et al. Diagnostic accuracy of high-resolution attenuation-correct‐
ed Anger camera SPECT in the detection of coronary artery disease. J Nucl Cardiol.
2014;21:127-34.
[33] Henzlova M, Cerqueira M, Christopher L, et al. Stress protocols and tracer. ASNC
imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol. 2010;17:646-54.
[34] Loscalzo J, Vita JA. Ischemia, hyperemia, exercise, and nitric oxide: Complex physiol‐
ogy and complex molecular adaptations. Circulation. 1994;90:2556-2559.
[35] Leppo JA. Comparison of pharmacologic stress agents. J Nucl Cardiol. 1996;3:S22-
S26.
[36] Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective ad‐
enosine A2A agonist, in patients with chronic obstructive pulmonary disease: A
randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol.
2008 May-Jun;15(3):319-28.
[37] Prenner BM, Bukofzer S, Behm S, et al. A randomized, double-blind, placebo-control‐
led study assessing the safety and tolerability of regadenoson in subjects with asthma
or chronic obstructive pulmonary disease. J Nucl Cardiol. 2012 Aug;19(4):681-92.
[38] Beller G, Zaret B. Contribution of nuclear cardiology to the diagnosis and prognosis
of coronary artery disease. Circulation. 2000;101:1465-1478.
[39] Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is
subject to selection bias. Biometrics. 1983;39:207-15.
[40] Iskandrian AE. Exercise MPI. In: Iskandrian AE, Verani MS, eds. Nuclear Cardiac
Imaging: Principles and Applications, 3rd ed. New York; Oxford University Press,
2003 pp. 151-163.
[41] Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical
use of cardiac radionuclide imaging–executive summary: A report of the American
College of Cardiology/American Heart Association Task Force on Practice Guide‐
lines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical
Use of Cardiac Radionuclide Imaging). Circulation. 2003;108:1404 -1418.
[42] Duvall WL, Guma KA, Kamen J, Croft LB, Parides M, George T, et al. Reduction in
occupational and patient radiation exposure from myocardial perfusion imaging: im‐
pact of stress-only imaging and high-efficiency SPECT camera technology. J Nucl
Med. 2013 Aug;54(8):1251-7.
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
67
[43] Chang SM, Nabi F, Xu J, Raza U, Mahmarian JJ. Normal stress only versus standard
stress/rest myocardial perfusion imaging: Similar patient mortality with reduced ra‐
diation exposure. J Am Coll Cardiol. 2010 Jan 19;55(3):221-30.
[44] Duvall WL, Wijetunga MN, Klein TM, Razzouk L, Godbold J, Croft LB, et al. The
prognosis of a normal stress-only Tc-99m myocardial perfusion imaging study. J
Nucl Cardiol. 2010 Jun;17(3):370-7.
[45] Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal exercise and ad‐
enosine (99m)Tc-tetrofosmin SPECT imaging: Results from the multicenter registry
of 4,728 patients. J Nucl Med. 2003 Feb;44(2):134-9.
[46] Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J
Nucl Cardiol. 2004;11:171-185.
[47] Acampa W, Petretta M, et al. Warranty period of normal stress myocardial perfusion
imaging in diabetic patients: A propensity score analysis. J Nucl Cardiol.
2014;21:50-6.
[48] Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in
patients without known coronary artery disease: Incremental prognostic value and
use in risk stratification. Circulation. 1996;93:905-914.
[49] Arasaratnam P, Ayoub C, et al. Positron emission tomography myocardial perfusion
imaging for diagnosis and risk stratification in obese patients. Curr Cardiovasc Imag‐
ing Re. 2015;8:9304.
[50] Lim SP, Arasaratnam P, et al. Obesity and the challenges of noninvasive imaging for
the detection of coronary artery disease. Canadian Journal of Cardiology.
2015;31:223-226.
[51] Machac J. Cardiac positron emission tomography imaging. Sem Nucl Med.
2005;35:17-36.
[52] Machac J, Bacharach S, et al. Quality assurance committee of the american society of
nuclear cardiology. Positron emission tomography myocardial perfusion and glucose
metabolism imaging. J Nucl Cardiol. 2006;13:e121-51.
[53] Dilsizian V, Bacharach S, Beanlands R, et al. PET myocardial perfusion and metabo‐
lism clinical imaging. J Nucl Cardiol. 2009;16:651.
[54] Baggish AL, Boucher CA. Radiopharmaceutical agents for myocardial perfusion
imaging. Circulation. 2008;118:1668-1674.
[55] Parker M, Iskander A, et al. Diagnostic accuracy of cardiac positron emission tomog‐
raphy versus single photon emission computed tomography for coronary artery dis‐
ease, a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5:700-707.
Coronary Artery Disease - Assessment, Surgery, Prevention68
[56] McArdle B, Dowsley T, et al. Does Rubidium-82 PET have superior accuracy to
SPECT perfusion imaging for the diagnosis of obstructive coronary artery disease? A
systematic review and met-analysis. J Am Coll Cardiol. 2012;60(18):1828-1837.
[57] Jaarsma C, Leiner T, et al. Diagnostic performance of noninvasive myocardial perfu‐
sion imaging using single-photon emission computed tomography, cardiac magnetic
resonance, and positron emission tomography imaging for the detection of obstruc‐
tive coronary artery disease: A meta-analysis. J Am Coll Cardiol. 2012;59:1719-28.
[58] Yoshinaga K, Chow BJ, Williams K, et al. What is the prognostic value of myocardial
perfusion imaging using rubidium-82 positron emission tomography? J Am Coll
Cardiol. 2006;48:1029-39.
[59] Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated
Rb-82 positron emission tomography myocardial perfusion imaging over clinical
variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2:846-54.
[60] Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term sur‐
vival benefit associated with revascularization compared with medical therapies in
patients with no prior coronary artery disease undergoing stress myocardial perfu‐
sion single photon emission computed tomography. Circulation. 2003;107:2900-2907.
[61] Naya M, Murthy V, et al. Prognostic interplay of coronary artery calcification and
underlying vascular dysfunction in patients with suspected coronary artery disease. J
Am Coll Cardiol. 2013;61:2098-106.
[62] Franke A, Hoffman R, Kuhl H. Non-contrast second harmonic imaging improves in‐
terobserver agreement and accuracy of dobutamine stress echocardiography in pa‐
tients with impaired image quality. Heart. 2000;83:133-40.
[63] Sozi F, Poldermans D, Bax J. Second harmonic imaging improves sensitivity of do‐
butamine stress echocardiography for the diagnosis of coronary artery disease. Am
Heart J. 2001;142:153-9.
[64] Kasprzak JD, Paelinck B, Ten Cate FJ, et al. Comparison of native and contrast-en‐
hanced harmonic echocardiography for visualization of left ventricular endocardial
border. Am J Cardiol. 1999;83:211-217.
[65] Pellikka P, Nagueh S, Elhendy A, et al. American Society of Echocardiography Rec‐
ommendations for Performance, Interpretation, and Application of Stress Echocar‐
diography. J Am Soc Echocardiogr. 2007;20(9):1021-41.
[66] Sicari R, Nihoyannopoulos P, Evangeslista A, et al. Stress echocardiography expert
consensus statement-executive summary: European Association of Echocardiogra‐
phy (EAE) (a registered branch of the ESC). Eur Heart Journal. 2009;30(3):278-89.
[67] Fox K, Garcia MA, Ardissino D, et al. Task Force on the Management of Stable Angi‐
na Pectoris of the European Society of Cardiology; ESC Committee for Practice
Guidelines (CPG): Guidelines on the management of stable angina pectoris: Execu‐
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
69
tive summary: The Task Force on the Management of Stable Angina Pectoris of the
European Society of Cardiology. Eur Heart J. 2006;27:1341-81.
[68] Bjork Ingul C, Rozis E, Slordahl SA, et.al. Incremental value of strain rate imaging to
wall motion analysis for prediction of outcome in patients undergoing dobutamine
stress echocardiography. Circulation. 2007;115:1252-9.
[69] Ingul CB, Stoylen A, Slodahl SA, et al. Automated analysis of myocardial deforma‐
tion at dobutamine stress echocardiography: An angiographic validation. J Am Coll
Cardiol. 2007;49:1651-9.
[70] Nagy AI, Sahlen A, Manouras A, et al. Combination of constrast-enhanced wall mo‐
tion analysis and myocardial deformation imaging using dobutamine stress echocar‐
diography. Eur Heart J. 2015;16:88-95.
[71] Beleslin BD, Osojic M, Djordjevic-Dikie A, et al. Integrated evaluation of relation be‐
tween coronary lesion features and stress echocardiography results: The importance
of coronary lesion morphology. J Am Coll Cardiol. 1999;33:717-26.
[72] Marwick TH. Stress echocardiography. Heart. 2003;89:113-8.
[73] Picano E, Bedetti G, Varga A, et al. The comparable diagnostic accuracies of dobuta‐
mine stress and dipyridamole-stress echocardiographies: a meta-analysis. Coron Ar‐
tery Dis. 2000;11:151e9.
[74] Ho FM, Huang PJ, Liau CS, et al. Dobutamine stress echocardiography compared
with dipyridamole thallium-201 single-photon emission computed tomography in
detecting coronary artery disease. Eur Heart J. 1995;16:570e5.
[75] Mahajan N, Polavaram N, Vankalaya et al. Diagnostic accuracy of myocardial perfu‐
sion imaging and stress echocardiography for the diagnosis of left main and triple
vessel coronary artery disease: A comparative meta-analysis. Heart. 2010;96:956-966.
[76] Innocenti F, Lazzeretti D, Conti A, et al. Stress echocardiography in the ED: Diagnos‐
tic performance in high-risk subgroups. Am J Emerg Med. 2013;31:1309-1314.
[77] Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocar‐
dial perfusion imaging and exercise echocardiography: A meta- analysis. J Am Coll
Cardiol. 2007;49(2):227-37.
[78] Arruda-Olson AM, Juracan EM, Mahoney DW, et al. Prognostic value of exercise
echocardiography in 5, 798 patients: Is there a gender difference: J Am Coll Cardiol.
2002;39(4):625-31.
[79] Schroder K, Wieckhorst A, Voller H. Comparison of the prognostic value of dipyri‐
damole and dobutamine stress echocardiography in patients with known or suspect‐
ed coronary artery disease. Am J Cardiol. 1997;79:1516-8.
[80] Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress
echocardiography in patients with known or suspected coronary artery disease: A
Coronary Artery Disease - Assessment, Surgery, Prevention70
prospective, large-scale, multicenter, head-to-head comparison between dipyrida‐
mole and dobutamine test. Echo-Per- santine International Cooperative (EPIC) and
Echo- Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardi‐
ol. 1999;34:1769-7.
[81] McCully Rb, Roger VL, Mahoney DW, et al. Outcome after abnormal exercise echo‐
cardiography for patients with good exercise capacity: Prognostic importance of the
extent and severity of exercise related left ventricular dysfunction. J Am Coll Cardiol.
2002;39(8):1345-52.
[82] Flohr TG, Stierstorfer K, Ulzheimer S, et al. Image reconstruction and image quality
evaluation for a 64-slice CT scanner with z-flying focal spot. Med Phys. 2005 Aug;
32(8):2536-47.
[83] Achenbach S, Raggi P. Imaging of coronary atherosclerosis by computed tomogra‐
phy. Eur H Journal. 2010;31:1442-48.
[84] Flohr TG, Mc Collough CH, Bruder H, et al. First performance evaluation of a dual-
source CT (DSCT) system. Eur Radiol. 2006;16:256-268.
[85] Tsukagoshi S, Ota T, Fujii M, et al. Improvement of spatial resolution in the longitu‐
dinal direction for isotropic imaging in helical CT. Phys Med Biol. 2007:52(3):791-801.
[86] Arbab Zadeh A, Hoe J. Multidetector CT angiography in comparison with conven‐
tional angiography. Methods, caveats and implications. J Am Coll Cardiol Imag.
2011:4(2):191-202.
[87] Taylor A, Cerqueira M, Hodgson J, et al. ACCF/SCCT/ACR /AHA /ASE / ASNC/
NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomogra‐
phy. A Report of the American College of Cardiology Foundation Appropriate Use
Criteria Task Force, the Society of Cardiovascular Computed Tomography, the
American College of Radiology, the American Heart Association, the American Soci‐
ety of Echocardiography, the American Society of Nuclear Cardiology, the North
American Society for Cardiovascular Imaging, the Society for Cardiovascular An‐
giography and Interventions, and the Society for Cardiovascular Magnetic Reso‐
nance. J Am Coll Cardiol. 2010;56(22):1864-1894.
[88] Budoff M, Dowe D, Jollis J, et al. Diagnostic performance of 64-multidetector row
coronary computed tomographic angiography for evaluation of coronary artery
stenosis in individuals without known coronary artery disease-results from the pro‐
spective multicenter accuracy (Assessment by Coronary Computed Tomographic
Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J
Am Coll Cardiol. 2008;52:1724-32.
[89] Meijboom WB, Meighem CA, Mollete NR, et al. 64-slice computed tomography coro‐
nary angiography in patients with high, intermediate, or low pretest probability of
significant coronary artery disease. J Am Coll Cardiol. 2007;50:1469-75.
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
71
[90] Litt HI, Gatsonis C, Snyder B, et al. CT angiography for safe discharge of patients
with possible acute coronary syndromes. N Engl J Med. 2012;366:1393-403.
[91] Hoffmann U, Truong QA, Schoenfeld DA, et al. Coronary CT angiography versus
standard evaluation in acute chest pain. N Engl J Med. 2012;367:299-308.
[92] Goldstein JA, Chinnaiyan KM, Abidov A, et al. The CT-STAT (coronary computed
tomographic angiography for systematic triage of acute chest pain patients to treat‐
ment) trial. J Am Coll Cardiol. 2011;58:1414-22.
[93] Chow BJ, Small G, Yam Y, et al. Incremental prognostic value of cardiac computed
tomography in coronary artery disease using CONFIRM: COroNary computed to‐
mography angiography evaluation for clinical outcomes: an InteRnational Multicen‐
ter registry. Circ Cardiovasc Imaging. 2011;4:463-72.
[94] Habib PJ, Green J, Butterfield RCA, et al. Association of cardiac events with coronary
artery disease detected by 64-slice or greater coronary CT angiography: A systematic
review and meta-analysis. Int J Cardiol. 2013; 169:112-120.
[95] Ostrom MP, Gopal A, Ahmadi N, et al. Mortality incidence and the severity of coro‐
nary atherosclerosis assessed by computed tomography angiography. J Am Coll Car‐
diol. 2008;52:1335-43.
[96] Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary
events in four racial or ethnic groups. N Engl J Med. 2008;358:1336-1345.
[97] P. Greenland, J. S. Alpert, G. A. Beller, et al. ACCF/AHA guideline for assessment of
cardiovascular risk in asymptomatic adults: A report of the American College of Car‐
diology Foundation/American Heart Association task force on practice guidelines.
Circulation. 2010;122:584-636.
[98] Shehata ML, Basha TA, Hayeri MR, et al. MR myocardial perfusion imaging: Insights
on techniques, analysis, interpretation, and findings. RadioGraphics. 2014;34:1636-57.
[99] Kim HW, Klem I, Kim R. Detection of myocardial ischemia by stress perfusion cardi‐
ovascular magnetic resonance. Cardiol Clin. 2007:25:57-70.
[100] Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for
the noninvasive detection of CAD. Circulation. 2003;108:432-437.
[101] Cury RC, Cattani CA, Gabure LA, et al. Diagnostic performance of stress perfusion
and delayed enhancement MR imaging in patients with coronary artery disease. Ra‐
diology. 2006;240:39-45.
[102] Kramer C, Barkhausen J, Flamm S, et al. Standardized cardiovascular magnetic reso‐
nance imaging (CMR) protocols, society for cardiovascular magnetic resonance:
Board of trustees task force on standardized protocols. J Cardiovasc Magn Reso‐
nance. 2008;10:35. doi:10.1186/1532-429X-10-35.
Coronary Artery Disease - Assessment, Surgery, Prevention72
[103] Hamon M, Fau G, Nee G, et al. Meta-analysis of the diagnostic performance of stress
perfusion cardiovascular magnetic resonance for detection of coronary artery dis‐
ease. J Cardiovasc Magn Reson. 2010;12:29.
[104] Manka R, Jahnke C, Gebker R, et al. Head-to-head comparison of first-pass MR per‐
fusion imaging during adenosine and high-dose dobutamine/atropine stress. Int J
Cardiovasc Imaging, 2011;27:995-1002.
[105] Schwitter J, Wacker C, van Rossum A, et al. MR-IMPACT: Comparison of perfusion-
cardiac magnetic resonance with single-photon emission computed tomography for
the detection of coronary artery disease in a multicenter, multivendor, randomized
trial. Eur Heart J. 2008;29:480-489.
[106] Chen M, Bandettini W, Shanbhag S, et al. Concordance and diagnostic accuracy of
vasodilator stress cardiac MRI and 320-detector row coronary CTA. Int J Cardiovasc
Imaging. 2014;30:109-119.
[107] Ingkanisorn W, Kwong R, Bohme N, et al. Prognosis of negative adenosine stress
magnetic resonance in patients presenting to an emergency department with chest
pain. J Am Coll Cardiol. 2006;47:1427-32.
[108] Lipinski M, McVey C, Berger J, et al. Prognostic value of stress cardiac magnetic reso‐
nance imaging in patients with known or suspected coronary artery disease. A Sys‐
tematic review and meta-analysis. J Am Coll Cardiol. 2013;62:826-38.
[109] Kelle S, Nagel E, Voss A, et al. A bi-center cardiovascular magnetic resonance prog‐
nosis study focusing on dobutamine wall motion and late gadolinium enhancement
in 3, 138 consecutive patients. J Am Coll Cardiol. 2013;61:2310-12.
[110] Douglas P, Hoffmann U, Patel M, et al. Outcomes of anatomical versus functional
testing for coronary artery disease. N Engl J Med. 2015;10.1056/NEJMoa1415516.
[111] Takx R, Blomberg B, Aidi H, et al. Diagnostic accuracy of stres myocardial perfusion
imaging to invasive coronary angiography with fractional flow reserve meta-analy‐
sis. Circ Cardiovasc Imaging. 2015;8:e002666. doi:10:1161/CIRCIMAGING.
114.002666.
Noninvasive Imaging for the Assessment of Coronary Artery Disease
http://dx.doi.org/10.5772/61502
73

